Cubist Systematic Strategies’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $374 | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $850K | Buy |
|
|||||
|
2023
Q1 | $17.7K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $38K | Sell |
|
|||||
|
2022
Q2 | $158K | Buy |
|
|||||
|
2022
Q1 | $109K | Buy |
|
|||||
|
2021
Q4 | $46K | Sell |
|
|||||
|
2021
Q3 | $441K | Buy |
|
|||||
|
2021
Q2 | $231K | Buy |
|
|||||
|
2021
Q1 | $0 | Sell |
|
|||||
|
2020
Q4 | $16K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $26K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $118K | Buy |
|
|||||
|
2019
Q3 | $27K | Buy |
|